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Abstract: Quitting smoking and participation in cardiac rehabilitation (CR) are effective strategies
in reducing morbidity and mortality. However, little is known about the predictors of quitting
smoking in those who attend CR. This study aimed to determine the sociodemographic and clinical
factors associated with the likelihood of CR attendees who are quitting smoking. Data from the UK
National Audit of Cardiac Rehabilitation (NACR) database, between April 2013 and March 2016,
were used. Smoking status is categorized as smokers and quitters, assessed by patient self-report.
The study used patient demographics, cardiovascular risk factors, comorbidities, and physical and
psychosocial health measures. Binary logistic regression was performed to identify the predictors
of quitting smoking among CR attendees. Of the 3290 patients who started CR and were entered
into the NACR database, 2052 were continued smokers (mean age 58.59 ± 10.49 years, 73.6% men)
and 1238 were quitters (mean age 57.63 ± 10.36 years, 75.8% men). The median duration of CR was
9 weeks. Compared to smokers, the quitters were younger, weighed more, were less anxious and
depressed, and were more likely to be employed. Single patients had 0.60 times lower odds (95% CI
0.43 to 0.82) of quitting smoking than patients with partners, and low-risk patients had 1.71 times
higher odds (95% CI 1.12 to 2.62) of quitting smoking than high-risk patients. Increasing number of
comorbidities and depression scores were associated with decreasing likelihood of quitting. This
study highlights the routine factors that determine smoking cessation outcomes, which could inform
the delivery of CR to better help patients to quit smoking.
Keywords: cardiac rehabilitation; smoking; quitting
1. Introduction
Smoking is a major risk factor for cardiovascular disease (CVD) and one of the biggest threats that
the world has ever faced, being the cause of death of more than 8 million people per year [1]. The
recent highly comprehensive meta-analysis of the link between smoking and CVD used data from 25
prospective cohorts in the Consortium on Health and Ageing: Network of Cohorts in Europe and the
United States (CHANCES). It found that smoking is a strong independent risk factor for CVD and
mortality in people aged ≥60 years [2]. This analysis found that smokers had a two-fold higher risk of
cardiovascular mortality as compared to non-smokers, smoking advanced the risk of death from CVD
by more than five years, smoking cessation in older adults is still beneficial, and the increased excess
risk among quitters declined with time after smoking cessation [2].
A meta-analysis of 12 cohort studies estimated that mortality in patients who continue to smoke
after myocardial infarction (MI) is 20% and suggested that smoking cessation is associated with a
significant decrease in mortality [3]. A retrospective analysis of data from an American study showed
that people who continued to smoke after percutaneous coronary revascularization had a 76% increased
risk of death after an average of 4.5 years of follow-up, as compared to non-smokers, and a 44% higher
risk of death compared to those who quit smoking [4].
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Stronger evidence comes from a 15-year follow-up of Dutch patients who underwent coronary
bypass surgery [5]. Patients whowere smoking 1 year after surgery had a risk of subsequentmyocardial
infraction and reoperation more than two times higher than that of patients who had quit smoking
since surgery [5]. Patients who were still smoking at 5 years after surgery had an even higher risk of
MI and reoperation and a significantly increased risk of angina pectoris, as compared to patients who
stopped smoking after surgery and patients who never smoked. Moreover, risks of MI were similar
among non-smokers and those who were successful in quitting after surgery [5].
Smoking is a major preventable risk factor for the development of non-communicable diseases,
including cardiovascular, respiratory diseases, and cancers [6]. Quitting smoking is the most
cost-effective strategy for CVD prevention [7]. A systematic review of 20 prospective cohort studies
showed that quitting smoking is associated with a 36% reduction in the risk of all-cause mortality
for patients with coronary heart disease who quit, compared to those who continued smoking [8].
International guidelines recommend that CVDprevention should be delivered in patients atmoderate to
high risk of CVD and patients with established CVD, by tackling smoking as a risk factor. Furthermore,
they considered quitting smoking as an important target in both primary and secondary prevention of
CVD [7,9–11]. Adopting healthy behaviors such as quitting smoking is the cornerstone of effective
preventive and control efforts of CVD. It is postulated that elimination of health-risk behaviors could
prevent at least 80% of cases of CVD and 40% of cancers [9–13].
Cardiac rehabilitation (CR), a comprehensive intervention offered to patients with CVD, is a
structured multidisciplinary intervention designed to target risk factors and psychosocial wellbeing
and supports smoking cessation in attempts to improve or maintain psychosocial wellbeing [7,9,14].
Participation in CR is associated with reduced cardiovascular mortality and hospital readmission
among other benefits [15]. Accordingly, patients in the United Kingdom (UK) and several other
countries have access to secondary prevention CR programs. Average uptake to UK CR programs
reached 50%, which is considered the highest uptake figures globally [16]. Across the UK, CR is
delivered in accordance with the British Association for Cardiovascular Prevention and Rehabilitation
(BACPR) standards, which aim to reduce cardiovascular risk and promote quality of life through
coordinated core components of CVD prevention and rehabilitation [9]. Through the lifestyle risk factor
management of its core component, the BACPR recommends supporting peoplewith smoking cessation
and relapse prevention [9]. The average proportion of patients who entered CR as non-smokers in
the UK was 94% [16]. CR is associated with an average increase in smoking cessation of one percent
(1.1%) [17].
Although extensive research was carried out on CR, little is known about the factors that are
associated with patients quitting smoking among CR participants. There is substantial evidence that
the demographic characteristics associated with quitting smoking include gender [18,19], age [18–21],
and marital status [22–26]. Smoking-related variables include tobacco dependence, the baseline
number of cigarettes smoked per day, the number of previous quit attempts, motivation to quit, and
the proportion of smokers in the household, all of which might influence the success of quitting
smoking [18,22,27–29]. Predictors of successful quitting include lower levels of depression [29,30].
Better designed observational studies are needed to determine the factors that are associated with
successfully quitting smoking in CR attendees. To date, research on the determinants of the likelihood
of quitting smoking among CR attendees is limited. A more thorough investigation is required to
identify the predictors of quitting smoking in CR, thus informing tailored interventions to increase
quitting smoking. This study investigates the sociodemographic and clinical factors associated with
the likelihood of quitting smoking among CR attendees.
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2. Methods
2.1. Data Source
The analyses were conducted using individual patient data collected electronically in the National
Audit of Cardiac Rehabilitation (NACR). The NACR is a web-based registry of CR in the UK, funded by
the British Heart Foundation. Practitioners involved in CR delivery electronically enter data on eligible
patients who are referred for CR into the individual patient dataset, according to a data dictionary
(www.cardiacrehabilitation.org.uk/nacr/downloads.htm), and the data quality is checked by a member
of the NACR team. The audit is voluntary, supports direct entry of data within a secure online system,
and collects local program-level data for those who are referred to and undergo CR. It includes details
of a patient’s initiating event, treatment type, risk factors, drugs, patient demographics, and post-CR
clinical outcomes. The NACR has approval to collect anonymized patient data for a range of clinical
variables, without explicit consent from individual patients, for the purposes of audit and research
under Section 251 of the NHS Act 2006 [16]. Approval is reviewed annually by NHS Digital. Separate
ethical approval was not required as a part of this research in addition to the e-survey project, which
is also an NACR audit process. This observational study was reported, following the guidelines of
the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines [31]
(Supplementary Materials: Table S1).
2.2. Participants
The research cohort included data from patients added to the NACR database between 1 April
2013 and 31 March 2016, which were validated and extracted retrospectively. The analysis included
data on sociodemographic and clinical characteristics for patients who started CR and had a smoking
status assessment at baseline (pre-CR) and follow-up (post-CR). There were no exclusion criteria.
2.3. Smoking Outcome Measures
Smoking status in the NACR database is recorded with information obtained by patient self-report
questionnaires [16]. Patients are categorized according to smoking status pre- and post-CR to one of
the following statuses:
• Never smoked
• Ex-smoker
• Stopped smoking since event
• Currently smoking.
From the smoking status record, pre- and post- for each CR patient, patients were defined, for the
purposes of this research, as:
• continued smokers, if they were current smokers in both the pre- and post-CR assessments.
• ex-smokers, if they were current smokers at the pre-CR assessment and stopping smoking status
at the post-CR assessment.
2.4. Baseline Characteristics
Numerous past studies used a variety of baseline characteristics to assess the difference between
continued smokers and quitters [18–21,26,32–34]. The present study used a variety of different patient
variables collected by the NACR primary dataset, including anthropometric data, sociodemographic
data, comorbidities, cardiovascular risk factors, and physical and psychosocial health measures.
Anthropometric measurements that are available in the NACR database include weight (kg), height
(m), body mass index (BMI) (kg/m2), and waist (cm). The sociodemographic data collected includes
age, gender, marital status, work status, and ethnicity.
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Comorbidities are any of the 19 commonly associated conditions that the patients who undergo
CR have, such as angina, diabetes, and cancer. These comorbidities are routinely collected by the
NACR and reported in the national statistical report [16]. Risk stratification is a multifactorial measure
used to establish prognosis of future major cardiac events or exercise complications, using all relevant
patient information, e.g., left ventricular ejection fraction, history of arrhythmia, symptoms, and
functional capacity [9,35–37]. Mortality risk within the first year is 2% for an individual assessed as
low risk, 10–25% for an individual assessed as moderate risk, and >25% for those assessed as high
risk [9,35–37]. If blood pressure (BP) is≥140/90mmHg, a patient is considered to have hypertension [38].
Alcohol consumption status in the NACR database is recorded using information obtained from
patient self-report questionnaires about weekly alcohol consumption [39]. Where a weekly unit
amount was recorded, the patient was allocated to the relevant category, based on their gender and the
recommended weekly units. The National Institute for Health and Care Excellence (NICE) guidelines
recommend that men should not regularly drink more than 21 units of alcohol per week and women
should not regularly drink more than 14 units of alcohol per week [40].
To evaluate the role of social deprivation, the study included the English Index of Multiple
Deprivation (IMD) Lower Layer Super Output Areas (LSOA) deprivation deciles, which linked to the
NACR [41]. These deciles are ranked from 1 to 10, where 1 means that that the LSOA is among the most
deprived 10% nationally and 10 represents the least deprived 10%. Self-reported moderate physical
activity (150 min/week; yes/no) and self-reported vigorous physical activity (75 min/week; yes/no))
conforming to the Department of Health guidelines for 19–64 and 65+ age groups [42]. Psychosocial
health status was assessed on the Hospital Anxiety and Depression Scale (HADS) scores, a reliable and
well-validated scale, with higher scores representing worse symptoms [43].
2.5. Statistical Analysis
All analyses were performed in the IBM Statistical Package for Social Sciences (SPSS) software
Version 26 (IBM, New York, NY, USA). p < 0.05 was considered to be statistically significant.
Smoking status was valued as 1 for quitters and 0 for smokers. Frequency tables were generated to
categorize CR patients as smokers and quitters, according to their recorded pre- and post-CR smoking
status. Analyses were conducted using all available data from CR attendees to minimize selection
bias. Continuous variables are shown as mean (standard deviation (SD)) and categorical variables as
frequencies (percentage).
Descriptive statistics were used to describe and compare a variety of sociodemographic and
baseline characteristics between smokers and quitters, among CR attendees in the UK. Both continuous
and categorical variables were used, depending on the method of data collection in the NACR.
Differences in baseline characteristics were then compared using independent-sample t-test for
continuous variables or chi-square test for categorical variables. Cohen’s d test was used as a measure
of the effect size to indicate the mean difference between two groups in standard deviation units [44].
In addition, a χ2 test for association was conducted between baseline sociodemographic and clinical
characteristics of smokers and quitters participating in CR [44]. Phi and Cramér’s V tests are a measure
of the effect size or strength of association of a nominal by nominal relationship [44]. Binary logistic
regression was used to predict the probability of quitting smoking among CR attendees. Variables
were considered in the equation for the binary logistic analysis, based on the extent of association
between smokers and quitters [45].
3. Results
3.1. Cohort Characteristics
The NACR cohort included 130,961 patients who started CR during the research period. A total
of 48,820 (37.3%) had a missing smoking status. Overall, 91.4% of patients who started CR and had
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a smoking status recorded were classified as non-smokers (31,832 had never smoked; 35,417 were
ex-smokers; 7,808 had stopped smoking since event).
Of the 49,725 patients who had their smoking status recorded pre- and post-CR, 46,435 (93.4%)
were classified as non-smokers (mean age 65.72 ± 11.08 years, 74.7% male), 2052 (4.1%) as continued
smokers (mean age 58.59 ± 10.49 years, 73.6% male), and 1238 (2.5%) as ex-smokers (mean age 57.63 ±
10.36 years, 75.8% male). The median duration of CR was 9 weeks. For the purposes of this research,
patients were categorized as either continued smokers or quitters (Table 1).
Table 1. Smoking categorization groups.
Group Frequency (n) Percent (%)
Smokers 2052 62.4
Quitters 1238 37.6
Total 3290 100
n = Number of patients; %, percentage of patients.
3.2. Baseline Characteristics
The mean baseline characteristics of smokers and quitters are summarized in Tables 2 and 3.
Table 2. Baseline characteristics of smokers and quitters participating in cardiac rehabilitation
(continuous measures).
Characteristics Group Mean (SD)/n
Effect Size
(Cohen’s d)
Age
Smokers 58.59 (10.49)/2052 *
0.09
Quitters 57.63 (10.36)/1238 *
Number of comorbidities
Smokers 1.85 (1.80)/2052 *
0.18
Quitters 1.54 (1.58)/1238 *
Weight
Smokers 81.63 (18.45)/1793 *
0.09
Quitters 83.27 (18.43)/1068 *
BMI
Smokers 28.03 (0.14)/1763
0.00
Quitters 28.03 (0.16)/1035
Waist
Smokers 98.72 (14.38)/918
0.01
Quitters 98.63 (15.33)/408
Alcohol
Smokers 9.09 (15.29)/1240
0.02
Quitters 8.78 (14.19)/641
HADS anxiety score
Smokers 7.31 (4.64)/1478 *
0.10
Quitters 6.84 (4.52)/743 *
HADS depression score
Smokers 5.96 (4.28)/1477 *
0.21
Quitters 5.08 (4.01)/744 *
IMD decile
Smokers 4.86 (2.90)/1585
0.01
Quitters 4.89 (2.90)/998
BMI—body mass index; HADS—hospital anxiety and depression scale; IMD—Index of multiple deprivation;
SD—standard deviation; n = number of patients. * p < 0.05.
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Table 3. Crosstabulation of baseline characteristics of smokers and quitters who participated in
cardiac rehabilitation.
Characteristics
Original Data (%) Effect Size
(Phi/Cramér’s V)Smokers Quitters
Gender
Male 73.6 75.8
–0.02
Female 26.4 24.2
Ethnic group
White 77.3 77.1
0.00
other 22.7 22.9
Marital status
Partnered 62.1 * 73.7 *
0.12
Single 37.9 * 26.3 *
Work status
Employed 33.6 * 44.8 *
0.11Unemployed 33.6 * 27.1 *
Retired 32.8 * 28.1 *
Cardiovascular risk
Low 39.5 * 49.3 *
0.10Moderate 38.9 * 34.6 *
High 21.6 * 16.2 *
BP > 140/80 mmHg
Yes 27.1 27.6
0.01
No 72.9 72.4
Exercise: 150 min/week of
moderate activity
Yes 30 29.8
0.00
No 70 70.2
Exercise: 75 min/week of
vigorous activity
Yes 7.5 6.4
0.00
No 92.5 93.6
BP—blood pressure. * p < 0.05.
An independent-samples t-test was run to determine whether sociodemographic and clinical
characteristics differed between smokers and quitters (Table 2).
A χ2 test for association was conducted between the baseline sociodemographic and clinical
characteristics and the two smoking categories—smokers and quitters participating in CR (Table 3).
The following characteristics were considered in the final model to identify CR attendees who
quit smoking:
• Age
• Marital status
• Employment status
• Cardiovascular risk
• Comorbidities
• Weight
• Hospital anxiety and depression scale (HADS)
• Anxiety score
• Depression score
A binary logistic regression was performed to ascertain the effects of the baseline characteristics
on the likelihood that CR attendees quit smoking (Table 4).
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Table 4. Binary logistic regression predicting likelihood of quitting smoking among patients who
attended cardiac rehabilitation.
B SE Wald df p OR
95% CI for OR
Lower Upper
Age –0.01 0.01 1.50 1.00 0.22 0.99 0.97 1.01
Marital status (single) –0.52 0.16 10.03 1.00 0.00 * 0.60 0.43 0.82
Employment status
(retired as reference)
Employment status (employed) 0.10 0.22 0.21 1.00 0.65 1.11 0.72 1.71
Employment status (unemployed) –0.20 0.24 0.69 1.00 0.41 0.82 0.52 1.30
Cardiovascular risk
(high as reference)
Cardiovascular risk (low) 0.54 0.22 6.10 1.00 0.01 * 1.71 1.12 2.62
Cardiovascular risk (moderate) 0.14 0.22 0.41 1.00 0.52 1.15 0.75 1.78
Comorbidities –0.13 0.05 7.48 1.00 0.01 * 0.88 0.80 0.96
Weight 0.01 0.00 2.11 1.00 0.15 1.01 1.00 1.01
HADS anxiety score 0.03 0.02 1.57 1.00 0.21 1.03 0.98 1.08
HADS depression score –0.06 0.03 4.16 1.00 0.04 * 0.95 0.90 1.00
Constant –0.11 0.86 0.02 1.00 0.90 0.90
B = unstandardized regression coefficient; CI = Confidence Interval for odds ratio; df—degrees of freedom;
HADS—hospital anxiety and depression scale; OR—odds ratio; SE—standard error of the coefficient. * p < 0.05.
The logistic regression model was statistically significant (χ2(10) = 59.32, p < 0.0001), explained
9.3% (Nagelkerke R2) of variance in smoking status, and correctly classified 64.7% of cases. Sensitivity
was 25.5%, specificity was 87.6%, positive predictive value was 54.5%, and negative predictive value
was 66.9%. The Hosmer–Lemeshow test in the final model was not statistically significant (p = 1.00),
indicating that the model was an appropriate fit.
Only four predictor variables were statistically significant—marital status, cardiovascular risk,
comorbidities, and HADS depression score (Table 4). Single patients had 0.60 times lower odds (95% CI
0.43 to 0.82) of quitting smoking than patients with partners, and low-risk patients had 1.71 times
higher odds (95% CI 1.12 to 2.62) of quitting smoking than high-risk patients. Increasing number of
comorbidities and HADS depression score was associated with decreasing likelihood of quitting.
4. Discussion
This retrospective secondary analysis of data from the NACR found that patients with high
cardiovascular risk, multiple comorbidities, no partner(s), and more severe depression were less likely
to quit smoking during CR. Age, comorbidities, cardiovascular risk, marital status, work status, weight,
HADS anxiety and depression scores expressed statistically significant differences between continued
smokers and quitters. Compared to continued smokers, quitters were younger, weighed more, had
fewer comorbidities, lower cardiovascular risk, were less anxious and depressed, were more likely to
have a partner and be employed. No meaningful differences in gender, social deprivation, or physical
activity were observed.
There was no gender difference in the likelihood of quitting smoking according to the results of
this research. Previous research found that demographic characteristics are associated with quitting
smoking; however, few such differences were identified by this research. For example, quitting smoking
had no relationship with gender and being female was not predictive of quitting smoking. This was
similar to the findings of numerous studies [20,26,34,46–50]. This is in contrast with other studies
whereby some studies reported the male gender to be a strong predictor of quitting smoking [18,19],
whilst other studies identified the female gender as a significant predictor of quitting smoking [23].
An important difference between this study and previous studies was the higher number of quitters in
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the sample and data from routine practice, which more closely resembled the range of patients in the
real-world clinical setting. In addition, the finding that being older was not an important determinant of
quitting smoking aligned with the results reported in a systematic review [50] by Hyland et al. [46] and
by Dawood et al. [29], but was not consistent with results of previous studies [18–21]. The Prospective
Registry Evaluating Outcomes After Myocardial Infarction Events and Recovery (PREMIER), with
2498 patients with MI from 19 US centers between January 2003 and June 2004, found that age and
gender were not associated with quitting smoking [29]. The observational research reported here
also showed that quitters were younger than smokers, indicating that older age was not a motivation
to quit, however, other studies suggested that older age was another strong predictor of successful
cessation [19,26,32,33,49,51].
On the other hand, a longitudinal study of the 2000 Thai adult smokers from the International
Tobacco Control Southeast Asia survey, with over four years of follow-up, found that age was a strong
independent predictor of quitting smoking, as older age was associated with increased success of
quitting smoking [20]. Only 176 (11.8%) of the Thai survey sample (n = 1489) were aged >65 years,
whereas 908 (27.60%) of the 3290 patients included in the analysis reported here were aged ≥65 years
old, giving a more appropriate sample size for the regression analysis. The results reported by
Jampaklay et al. were also consistent with those of Li et al. and Osler and Prescott in Asia and Western
Europe, respectively [18–20]. Jampaklay et al. suggested that this might be because older people were
more likely to experience health problems and thus were more motivated to quit. The percentage
of smokers aged ≥55 years in the study reported by Li et al. was 23.9% in Malaysia and 31.1% in
Thailand [18], compared to 63.53% in the study reported here. Osler and Prescott found that quitting
smoking was associated with older age [19]; however, this study did not include individuals aged
≥60 years, while the research reported here included 1336 (40.61%) patients aged ≥60 years.
Single patients had 0.60 times lower odds of quitting smoking than patients with partners. Marital
status was identified as a major predictor of quitting smoking. This was similar to the findings of
the British Household Panel Survey from 1991 to 2000, in which marital status was an important
sociodemographic predictor of quitting smoking [22]; the findings of Kim, who reported that being
married was a significant predictor of successful smoking cessation in patients in the fourth Korea
National Health and Nutrition Examination Survey (KNHANES) [23]; and the findings of West et al.
who reported that smokers whose partners objected to smoking were more likely to quit [24]. Other
studies also identified being married as a significant predictor of quitting smoking [22,25,29]. Although
Vangeli et al. found that marital status was not related to quitting smoking, the study included the adult
general population, while the research reported here included patients with CVD [50]. Moreover, these
findings were consistent with the results of the large population-based sample from the 2000 National
Health Interview Survey of adults in the US, which showed that quitters were more likely to be married
or living with a partner [26]. The US Public Health Service clinical practice guideline also states that
social support during smoking cessation increases the likelihood of quitting smoking and recommends
that smokers are counselled to ask for social support from their spouse or partner(s), friends, and
co-workers [52]. Quitting smoking thus seems to be influenced strongly by the social environment,
and CR programs that promote smoking cessation might benefit from involving partner(s)/spouse to
encourage smoking cessation. In addition, the PREMIER study found that patients who quit smoking
were more likely to be married [29].
Patients with multiple comorbidities had decreased odds of quitting smoking; in contrast, low-risk
patients were associated with higher odds of quitting smoking than high-risk patients. Holtrop et al.
found that the presence of comorbidities in CVD patients was not associated with quitting smoking [28].
However, the results of the study might not be generalizable as it only included 136 patients (mean age
53.32 ± 9.52 years) and enrolled patients in two similar communities. Whereas in our study, 3290 CVD
patients (mean age 58.23 ± 10.45 years) were included and were pooled from different communities.
Numerous studies addressed the impact of individual sociodemographic characteristics or clinical
measures on quitting smoking. Unlike previously cited work, a strength of our study was that our
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analysis accounted for known confounders such as sociodemographic characteristics, clinical measures,
cardiovascular risk, and comorbidity profile. Although a Danish study found that self-rated health
status was not associated with quitting smoking, it suggested that patients with high cardiovascular
risk and multiple comorbidities were less likely to quit smoking [19], which is similar to the findings of
the research reported here.
Patients with a higher HADS depression score had decreased odds of quitting smoking. This was
in line with the finding of a meta-analysis of 42 trials by Hitsman et al., in which major depression had
a moderate adverse effect on quitting smoking [53]. This finding was also in agreement with previous
studies that concluded that patients who quit smoking were less likely to have depression and that
depression greatly decreased the likelihood of quitting smoking [29,30].
The findings showed that identification of characteristics that predict quitting smoking among
CR attendees is highly desirable, as this could help match smokers with strategies that are more
likely to help them quit, identify smokers who might need more intensive treatment (who would then
require referral to specialist centers), and make the most of healthcare resources. Programs designed
to encourage smokers to quit might need to account for factors related to partner support as part of
an existing prevention program, to encourage smokers to quit. A more wide-ranging CR offer and
tailored intervention is suggested to help smokers quit, as the research findings highlight that CR
programs need to prioritize patients with multiple comorbidities, high cardiovascular risk, more severe
depression, and no partner(s). In future trials, it would be useful to pay increased attention to the
recruitment of patients who are more representative of the broader CVD population, including those
at higher risk and with major comorbidities. Clinical and research efforts should be directed towards
improving the rate of smoking cessation in patients with CVD.
The strength of this study lies in the use of an observational approach based on routinely collected
patient data, and the use of a large dataset taken from routine clinical practice and representing a CR
intervention with a median duration of nine weeks.
Retrospective observational studies have known limitations in terms of data capture and the
quality of the 230 CR programs in the UK—according to the 2019 NACR report, only 189 (82%)
programs entered data electronically to the NACR. Although it can be argued that there is enough data
to be representative and carry out a reliable analysis, future work should aim to achieve greater capture
of available data across the UK. Although CR programs are encouraged to provide complete patient
records, a proportion of patient data was expected to be missing due to non-completion of patient
records. On the basis of the NACR data, 68.6% of all patients who started CR did not have a post-CR
assessment recorded, which might have affected the representativeness of the research sample.
A limitation of the study was the use of self-reported data to determine smoking status, which
might be subject to recall and social desirability biases. The self-reported smoking status was not
validated with a biochemical marker. Some relevant factors that influenced quitting smoking were
missing from the analysis, due to high levels of missing data—variables with more than 60% missing
values were eliminated from the dataset (such as physical fitness) and some might not have been
collected in the NACR. Some characteristics known to influence quitting smoking in the literature
were not collected by the NACR, such as motivation to stop smoking, number of cigarettes per day,
proportion of smokers in the household, and exposure to warning labels [18,22,27].
5. Conclusions
Patients with high cardiovascular risk, multiple comorbidities, no partner(s), and more severe
depression were less likely to quit smoking during CR. This research highlights routine factors that
determine smoking cessation outcomes and that could inform the delivery of CR to better help patients
in quitting smoking.
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